ReviewTransplantation and cellular therapy2021

Meeting the Demand for Unrelated Donors in the Midst of the COVID-19 Pandemic: Rapid Adaptations by the National Marrow Donor Program and Its Network Partners Ensured a Safe Supply of Donor Products.

Jeffery J Auletta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.